Search results
Results from the WOW.Com Content Network
Weight gain. Some side effects, such as weight gain, occur more frequently with certain types of antidepressant medication. ... (duloxetine), Effexor XR (venlafaxine) and Pristiq (desvenlafaxine ...
However, many are associated with an infamous side effect: weight gain. Luckily, some antidepressants are less likely to cause weight gain than others. In fact, there are even some antidepressants ...
Venlafaxine, sold under the brand name Effexor among others, is an antidepressant medication of the serotonin–norepinephrine reuptake inhibitor (SNRI) class. [6] [9] It is used to treat major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder. [9]
Effexor: Major depressive disorder; Generalized anxiety disorder; Social anxiety disorder; Panic disorder; Chronic pain syndromes [20] Vasomotor symptoms of menopause (hot flashes) [21] 1994: The first and most commonly used SNRI. It was introduced by Wyeth in 1994. The reuptake effects of venlafaxine are dose-dependent.
Anxiety disorders — characterized by uneasiness, worry, and fear — can cause various symptoms that affect how you think and behave. This can include changes in appetite (aka your body’s ...
Headache — an often transient side effect that is common to most serotonin reuptake inhibitors and that most often occurs at the beginning of therapy or after a dose escalation. Nausea — an adverse effect that is more common with venlafaxine than with the SSRIs. Usually transient and less severe in those receiving the extended release ...
Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic, fat-soluble, S-acyl derivative of thiamine (vitamin B1) that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in late 1950s in Japan. [1] [2]
Although usually reversible, these sexual side-effects can, in rare cases, continue after the drug has been completely withdrawn. [ 158 ] [ 159 ] In a study of 1,022 outpatients, overall sexual dysfunction with all antidepressants averaged 59.1% [ 160 ] with SSRI values between 57% and 73%, mirtazapine 24%, nefazodone 8%, amineptine 7%, and ...